Literature DB >> 25200637

Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Karlo Perica1, Alyssa K Kosmides1, Jonathan P Schneck2.   

Abstract

Artificial antigen presenting cells (aAPCs) are engineered platforms for T cell activation and expansion, synthesized by coupling T cell activating proteins to the surface of cell lines or biocompatible particles. They can serve both as model systems to study the basic aspects of T cell signaling and translationally as novel approaches for either active or adoptive immunotherapy. Historically, these reductionist systems have not been designed to mimic the temporally and spatially complex interactions observed during endogenous T cell-APC contact, which include receptor organization at both micro- and nanoscales and dynamic changes in cell and membrane morphologies. Here, we review how particle size and shape, as well as heterogenous distribution of T cell activating proteins on the particle surface, are critical aspects of aAPC design. In doing so, we demonstrate how insights derived from endogenous T cell activation can be applied to optimize aAPC, and in turn how aAPC platforms can be used to better understand endogenous T cell stimulation. This article is part of a Special Issue entitled: Nanoscale membrane organisation and signalling.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial antigen presenting cell; Immunotherapy; Microparticle; Microscale interaction; Nanoscale interaction

Mesh:

Year:  2014        PMID: 25200637      PMCID: PMC4344884          DOI: 10.1016/j.bbamcr.2014.09.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  178 in total

1.  Full activation of the T cell receptor requires both clustering and conformational changes at CD3.

Authors:  Susana Minguet; Mahima Swamy; Balbino Alarcón; Immanuel F Luescher; Wolfgang W A Schamel
Journal:  Immunity       Date:  2006-12-21       Impact factor: 31.745

2.  An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 molecules.

Authors:  Shinji Kondo; Ayako Demachi-Okamura; Tomoya Hirosawa; Hiroyuki Maki; Mitsugu Fujita; Yasushi Uemura; Yoshiki Akatsuka; Eiko Yamamoto; Kiyosumi Shibata; Kazuhiko Ino; Fumitaka Kikkawa; Kiyotaka Kuzushima
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

3.  In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density.

Authors:  I Motta; Y C Lone; P Kourilsky
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

4.  Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis.

Authors:  Julie M Curtsinger; Debra C Lins; Christopher M Johnson; Matthew F Mescher
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.

Authors:  S R Riddell; P D Greenberg
Journal:  J Immunol Methods       Date:  1990-04-17       Impact factor: 2.303

6.  Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.

Authors:  Ying-Chun Lo; Michael A Edidin; Jonathan D Powell
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

Review 7.  Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.

Authors:  Mathias Oelke; Jonathan P Schneck
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  CD28 and CD3 have complementary roles in T-cell traction forces.

Authors:  Keenan T Bashour; Alexander Gondarenko; Haoqian Chen; Keyue Shen; Xin Liu; Morgan Huse; James C Hone; Lance C Kam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 9.  Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains.

Authors:  Anne B Vogt; Sebastian Spindeldreher; Harald Kropshofer
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

10.  Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

Authors:  S Della Bella; M Gennaro; M Vaccari; C Ferraris; S Nicola; A Riva; M Clerici; M Greco; M L Villa
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

View more
  20 in total

Review 1.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

2.  Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells.

Authors:  Fatemeh S Majedi; Mohammad Mahdi Hasani-Sadrabadi; Timothy J Thauland; Song Li; Louis-S Bouchard; Manish J Butte
Journal:  Nano Lett       Date:  2019-09-03       Impact factor: 11.189

Review 3.  Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.

Authors:  Luo Gu; David J Mooney
Journal:  Nat Rev Cancer       Date:  2016-01       Impact factor: 60.716

4.  Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell Activation.

Authors:  Brynn R Olden; Caleb R Perez; Ashley L Wilson; Ian I Cardle; Yu-Shen Lin; Bryan Kaehr; Joshua A Gustafson; Michael C Jensen; Suzie H Pun
Journal:  Adv Healthc Mater       Date:  2018-12-13       Impact factor: 9.933

Review 5.  Soluble MHC class I complexes for targeted immunotherapy.

Authors:  Anna Schappert; Jonathan P Schneck; Lauren Suarez; Mathias Oelke; Christian Schütz
Journal:  Life Sci       Date:  2018-08-10       Impact factor: 5.037

Review 6.  Biomimetic particles as therapeutics.

Authors:  Randall A Meyer; Joel C Sunshine; Jordan J Green
Journal:  Trends Biotechnol       Date:  2015-08-12       Impact factor: 19.536

7.  Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.

Authors:  Xuqing Zhang; Mengyao Luo; Shamael R Dastagir; Mellissa Nixon; Annie Khamhoung; Andrea Schmidt; Albert Lee; Naren Subbiah; Douglas C McLaughlin; Christopher L Moore; Mary Gribble; Nicholas Bayhi; Viral Amin; Ryan Pepi; Sneha Pawar; Timothy J Lyford; Vikram Soman; Jennifer Mellen; Christopher L Carpenter; Laurence A Turka; Thomas J Wickham; Tiffany F Chen
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

8.  Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation.

Authors:  Alyssa K Kosmides; Kevin Necochea; John W Hickey; Jonathan P Schneck
Journal:  Nano Lett       Date:  2018-02-28       Impact factor: 11.189

9.  How to Quantify Penile Corpus Cavernosum Structures with Histomorphometry: Comparison of Two Methods.

Authors:  Bruno Felix-Patrício; Diogo Benchimol De Souza; Bianca Martins Gregório; Waldemar Silva Costa; Francisco José Sampaio
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

10.  Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.

Authors:  John W Hickey; Fernando P Vicente; Gregory P Howard; Hai-Quan Mao; Jonathan P Schneck
Journal:  Nano Lett       Date:  2017-10-10       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.